When carbohydrate is administered to a healthy human as diet, blood glucose level rises temporally, then slowly lowers to about 100 mg/dl where it remains constant. In the case of a patient with diabetes, the glucose level rises steeply and hyperglycemia (Ͼ200 mg/dl) occurs. Hyperglycemia is known to cause many complications such as cataract, arteriosclerosis, neuralgia, etc. [1] [2] [3] [4] To suppress hyperglycemia, a-glucosidase (EC 3.2.1.20) inhibitors, acarbose 5, 6) and [7] [8] [9] [10] [11] have been used as oral agents for treatment of diabetes. Although these drugs show potent pharmacological action, they have such side effects as abdominal pain, flatus, diarrhea, and soft feces in the colon. 12,13) The abdominal distress occurs because of the fermentation of maltose which accumulates as a result of a-glucosidase inhibition.
1
-amino-6 1 -deoxymaltotriose for porcine pancreatic a-amylase, and Arai et al. 18) indicated inhibition of modified maltooligosaccharides having deoxynojirimycin residue at the reducing end for microbial and animal a-amylases. Many iminocyclitols showed strong inhibitory activities for a-glucosidases. [19] [20] [21] We therefore designed fifteen new modified maltooligosaccharides having N-containing pseudo sugar residues; these were three kinds of iminocyclitols [19] [20] [21] with 6-amino-6-deoxysorbitol 22) at the reducing end ( Fig. 1 ). In this paper we describe the synthesis of these newly modified maltooligosaccharides and discuss the effects of various N-containing pseudo sugars and glucosyl chain length on the inhibitory activities of human a-amylases and rat maltase. Suppression activities of postprandial hyperglycemia for ICR mice are also reported.
having 6 1 -azido-6 1 -deoxygluconic acid residue at the reducing end (not purified). After removal of the excess Br 2 under reduced pressure, oxidative decarboxylation 24) with Fe 2 (SO 4 ) 3 and H 2 O 2 at 40°C gave 5-azido-5-deoxyarabinosyl derivatives (not purified). They were then reduced by catalytic hydrogenation over palladium-on-charcoal in H 2 O to yield the corresponding iminocyclitol: 16 from 1 (overall yield 14%), 17 from 2 (overall yield 11%), 18 from 3 (overall yield 23%), 19 from 4 (overall yield 12%), or 20 from 5 (overall yield 11%).
Kitahata et al. 25) reported that D-xylose is a good acceptor for transglycosylation with soluble starch using CGTase. Transglycosylation of deoxynojirimycin (a glucose type iminocyclitol) with soluble starch using CGTase was also reported. 18) These results led us to expect that the CGTase could catalyze the transglycosylation of (3S,5R)-3,4,5-trihydroxypiperidine 21) (21, a xylose type iminocyclitol) with a-CD to give 3-piperidine (D)-type derivatives (Chart 2). As we expected, incubation of 21 with a-CD and CGTase, and subsequent b-amylase hydrolysis gave 22 (yield 3%), 23 (yield 27%), and 24 (yield 16%), respectively. Additionally, (3R,4R,5S)-4,5-dihydroxypiperidine-3-yl tris[O-a -D-glucopyranosyl-(1→4)]-a-D-glucopyranoside was produced in a trace amount.
Structural Elucidation of Modified Oligosaccharides Structures of the synthesized compounds were established by spectral data and elemental analyses.
We determined the numbers of glucosyl residue in the compounds (A-, B-, C-, D-) from the integration of 1 H-NMR signals at d 5.4 (Jϭ3.9 Hz) assigned to each glucosyl H-1. In the case of D-type compounds, the linkage between glucose and piperidine residue was elucidated by 1 H-and 13 C-NMR. The anomeric type of the linkage was determined to be a by the doublet signal assigned to H-1 d 5.21 (Jϭ3.9 Hz). Although the 13 C-NMR spectrum of 21 showed only three signals because of its symmetry, compound 22 showed eleven signals and a downfield shift (ϩ8.79 ppm) of the C-3 signal of the piperidine residue (Table 1) . Arai et al. 18) also reported that downfield shift (ϩ7.62 ppm) was observed at the C-4 signal on deoxynojirimycin moiety of a-D-glucopyranosyl-(1→4)-deoxynojirimycin, compared with the chemical shift of deoxynojirimycin. Thus the linkage between glucose residue and piperidine residue was elucidated to be a-(1→3), not to be a-(1→4). Linkage of the other compounds (23, 24) was determined in a similar manner.
Inhibition of Human a a-Amylases by the N-Containing Sugars Inhibitory activities of the compounds were determined against human pancreatic a-amylase (HPA) and human salivary a-amylase (HSA) and are shown in Table 2 .
We earlier reported that 6 3 -deoxymaltotriose ( Fig. 2 ) showed a large difference in inhibitory activity between HPA (IC 50 ϭ2.0 mM) and HSA (IC 50 ϭ42 mM). [14] [15] [16] A-type derivatives (8-9), B-type derivatives (13) (14) (15) , and C-type derivatives (18) (19) (20) showed stronger activity than 6 3 -deoxymaltotriose, and these compounds did not show remarkable difference in inhibitory activity between the two a-amylases.
In the same chain length, the activity of B-type derivatives (12) (13) (14) (15) and C-type derivatives (17) (18) (19) (20) was stronger than that of A-type derivatives (7) (8) (9) (10) . Optimal chain length for strong a-amylase inhibition was three or four. With regard to the specificity of the structure of N-containing sugar, D-type derivatives (22) (23) (24) have similar piperidine ring to C-type derivatives (17) (18) (19) , but did not show inhibitory activity (under 5 mM). It is presumed that an important role in a-amylase inhibition is played not only by amino groups but also by hydroxyl groups located on either side of the glucosyl position.
HPA and HSA have been shown to have five to seven binding sites, called subsites, for glucose residues of substrate. [26] [27] [28] [29] From our results, glucose residues of a strong inhibitor may be bound to subsites-2 to -3 or -2 to -4, and the amino groups of N-containing sugar moiety at subsite-1 seem to cause ionic interaction with the enzymes at the active site (Fig. 3) .
Inhibition of Rat Intestinal Maltase by the N-Containing Sugars The IC 50 values of the compounds 6-24 are shown in Table 1 . All tested compounds showed weak or no inhibition against the maltase.
Suppression Test of Postprandial Hyperglycemia Since 13 and 18 showed strong inhibitory activity for the two aamylases but had no inhibitory activity for maltase, the two compounds were selected for use in the suppression test. When cornstarch and 13 or 18 were orally administered to ICR mice, the rise in blood glucose concentration was significantly suppressed compared to the control (Fig. 4) . After administration, neither death nor a side effect such as diarrhea 
a) IC 50 : molar concentration required to give 50% inhibition. b) Less than 50% inhibition at 5.0 mM. C) Less than 50% inhibition at 10 mM.
Fig. 2. Chemical Structure of 6
3 -Deoxymaltotriose or soft feces was observed. IC 50 value of 13 (0.060 mM) or 18 (0.041 mM) for pancreatic a-amylase of ICR mice was almost equal to that of HPA. Result of the suppression test for mouse hyperglycemia was thus believed to reflect suppression in the case of human.
In conclusion, we synthesized four new types of N-containing maltooligosaccharides by an elegant chemoenzymatic method. For inhibition of two human a-amylases, effective units at the reducing end of maltooligosaccharides were Btype or C-type, and the optimal chain length of glucose residue was three or four. We also showed the possibility that 13 or 18 might be used as an oral agent for treatment of diabetes.
Experimental
Reagents and Materials All chemicals were reagent grade unless otherwise noted. An a-amylase activity determination kit (Neo · Amylase Test Daiichi) using blue starch as a substrate was obtained from Daiichi Pure Chemicals Co., Ltd., Japan. A glucose quantitative kit (Glucose B-test Wako) and b-amylase (from wheat) were obtained from Wako Pure Chemical Industries, Ltd., Japan. Standard HPA and HSA were obtained from International Reagents Corp., Japan. CGTase (from Bacillus macerans) was purchased from Amano Co., Ltd., Japan, and glucoamylase (from Rhizopus sp.) from Toyobo Co., Ltd., Japan.
Apparatus All melting points were determined on a Yanagimoto micromelting point apparatus and are uncorrected. Optical rotations were determined with a JASCO DIP-360 digital polarimeter at 25°C. IR spectra were recorded with a JASCO FT/IR-7300 spectrometer. 1 H-NMR spectra were recorded at 199.5 or 500.1 MHz and 13 C-NMR spectra were taken at 50.10 or 125.7 MHz with a JEOL JNM-FX200 or Bruker AVANCE 500 spectrometer using sodium 3-(trimethylsilyl)propionate as an internal standard and D 2 O as a solvent. HPLC was performed on a (A) TSK gel Amide-80 column (4.6 mm i.d.ϫ250 mm) or (B) TSK gel Amino-60 column (4.6 mm i.d.ϫ250 mm) with a flow rate of 1.0 ml/min using a JASCO pump (880-PU) and a refractive index detector (Shodex RI SE-71) at room temperature. Visible absorption (620 nm) was recorded with a Hitachi 557 spectrometer. Blood glucose concentration was measured with an ANTSENSE (Bayer-Sankyo).
Preparation of Compounds 2-5 CGTase (1.4 ml, 840 U) was added to a stirred solution of a-CD (180 g, 185 mmol) and 1 23) (10 g, 49 mmol) in 10 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES) buffer (pH 5.2, 1.0 l), and the mixture was stirred at 37°C for 50 min. The solution was boiled for 30 min to inactivate the enzyme. After cooling, 1.1 g (367 U) of bamylase was added and the mixture was stirred at 37°C for 5.5 h, then boiled for 1 h to stop the reaction. After cooling, toluene (100 ml) was added and the mixture was stirred at room temperature for 5 h; the insoluble materials were removed by filtration with a short pad of Celite ® . The filtrate was then evaporated under reduced pressure to about 100 ml and the solution was passed through an active carbon column. Vol. 47, No. 2
Fig. 3. Binding Model of Synthesized Inhibitors on the Subsites of Human a-Amylases
The arrowhead indicates the catalytic site and each sequentially numbered box represents a subsite. C-6a), 63.37 (C-6b-e) General Procedure for the Preparation of Compounds 6-10 Sodium borohydride (5-10 mol eq for 1-5) was added to a solution of 1 (1.50 g, 7.31 mmol), 2 (1.50 g, 4.08 mmol), 3 (1.0 g, 1.89 mmol), 4 (1.2 g, 1.74 mmol), or 5 (1.0 g, 1.17 mmol) in DMF (80-150 ml), and the mixture was stirred at 80°C for 6 h. The mixture was neutralized with HCl (1 M), and then evaporated under reduced pressure to leave a syrupy residue. This residue was chromatographed on ion-exchange gel (Dowex 1ϫ4, OH Ϫ form) with H 2 O, and the appropriate fractions were freeze-dried to give 6 (0.69 g, 3.81 mmol, 52%), 7 (0.51 g, 1.49 mmol, 37%), 8 (0.50 g, 0.99 mmol, 52%), 9 (0.52 g, 0.78 mmol, 45%), or 10 (0.65 g, 0.78 mol, 67%), respectively.
6-Amino-6-deoxy-D-sorbitol (6) (100-300 mg) and H 2 O 2 (600-1000 ml) were added to the stirred reaction mixture, and the mixture was stirred at 40°C for 8 h. It was then passed through an active carbon column using an EtOH-H 2 O gradient of 0 to 50% and the appropriate fractions were freeze-dried. Each semipurified intermediate in distilled water (30-60 ml) was stirred vigorously over 10% Pd/C (0.45-1.0 g) under H 2 at ordinary pressure for 16 h. The Pd/C was removed by filtration with a short pad of Celite 
